{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:04:33Z","timestamp":1762254273169},"reference-count":12,"publisher":"American Medical Association (AMA)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2022,10,4]]},"DOI":"10.1001\/jama.2022.14912","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T15:02:10Z","timestamp":1664895730000},"page":"1302","source":"Crossref","is-referenced-by-count":3,"title":["Telmisartan and Walking Performance in Peripheral Artery Disease"],"prefix":"10.1001","volume":"328","author":[{"given":"Marc P.","family":"Bonaca","sequence":"first","affiliation":[{"name":"Colorado Prevention Center, Aurora"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie","family":"Hess","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Colorado, Aurora"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua A.","family":"Beckman","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"12","key":"jed220067r1","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","article-title":"Epidemiology of peripheral artery disease and polyvascular disease.","volume":"128","author":"Aday","year":"2021","journal-title":"Circ Res"},{"issue":"11","key":"jed220067r2","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.jacc.2016.11.008","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease.","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"jed220067r3","first-page":"2090","article-title":"Rivaroxaban in peripheral artery disease after revascularization.","volume":"383","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"key":"jed220067r4","article-title":"Effect of telmisartan on walking performance in patients with lower extremity peripheral artery disease: the TELEX randomized clinical trial.","author":"McDermott","journal-title":"JAMA"},{"issue":"17","key":"jed220067r5","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1161\/CIRCULATIONAHA.118.033348","article-title":"Association of blood pressure measurements with peripheral artery disease events.","volume":"138","author":"Itoga","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"jed220067r6","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jacc.2003.11.029","article-title":"Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy.","volume":"43","author":"Julius","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"jed220067r7","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1161\/CIRCRESAHA.116.303566","article-title":"Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease.","volume":"116","author":"Hiatt","year":"2015","journal-title":"Circ Res"},{"issue":"6","key":"jed220067r8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1161\/CIRCULATIONAHA.119.040672","article-title":"Microvascular disease, peripheral artery disease, and amputation.","volume":"140","author":"Beckman","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"jed220067r9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/1358863X221085606","article-title":"Improvement in walking impairment following surgical and endovascular revascularization.","volume":"27","author":"Hogan","year":"2022","journal-title":"Vasc Med"},{"issue":"8","key":"jed220067r10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.007953","article-title":"Supervised exercise therapy for symptomatic peripheral artery disease among Medicare beneficiaries between 2017 and 2018.","volume":"14","author":"Divakaran","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"24","key":"jed220067r11","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1016\/j.jacc.2021.04.060","article-title":"Effectiveness of blood lipid management in patients with peripheral artery disease.","volume":"77","author":"Hess","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"jed220067r12","unstructured":"American Heart Association. Peripheral artery disease: national action plan. Accessed September 19, 2022. https:\/\/www.heart.org\/en\/health-topics\/peripheral-artery-disease\/pad-resources\/pad-action-plan"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2796969\/jama_bonaca_2022_ed_220067_1664214362.66194.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T15:02:18Z","timestamp":1664895738000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2796969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":12,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,10,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.14912","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,4]]}}}